News
ABT
104.97
-0.93%
-0.99
Integer Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
NASDAQ · 8h ago
Peering Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's short percent of float has fallen 17.33% since its last report. The company has 10.75 million shares sold short, which is 0.62% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 11h ago
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Dexcom (NASDAQ:DXCM) stock is down over 40% after reporting disappointing revenue for the second quarter. The company lowered guidance for the rest of the year and delayed the launch of its Stelo continuous glucose monitor. Stelo monitors deliver data to the Apple Watch or other devices via Bluetooth.
Investorplace · 11h ago
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down
NASDAQ · 14h ago
Aristotle Core Equity Q2 2024 Commentary
Seeking Alpha · 14h ago
Better Buy: Abbott Laboratories vs. Intuitive Surgical
Abbott Laboratories and Intuitive Surgical are both in the medical technology industry. Demand for devices that enable minimally invasive surgical procedures and remote monitoring is on the rise. Abbott Laboratories is the better stock to buy now and hold for the long run. The company is the first to market robotic-assisted surgical systems.
The Motley Fool · 16h ago
DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures
DexCom reported disappointing earnings, missing estimates by 4% and lowering full-year growth expectations by $200 million. Sales in the U.S. Market slowed, while international markets saw anemic growth. Markets blamed sales on poor sales execution, complicated by inefficient distribution channels. Despite strong earnings, DXCM faces challenges with distribution channels and growing competition, leading to a downgrade to Hold.
Seeking Alpha · 20h ago
S&P 500's Biggest Loser Has a Heart Valve Problem
The Wall Street Journal · 1d ago
The Zacks Analyst Blog Highlights SAP, Abbott Laboratories, Citigroup, Team and Vaso
NASDAQ · 1d ago
Align Technology (ALGN) Beats on Q2 Earnings, Lowers '24 Sales View
NASDAQ · 1d ago
Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
NASDAQ · 1d ago
3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years
Abbott Laboratories, Home Depot and JPMorgan Chase are good dividend stocks for retirees. These stocks provide good yields and they don't come with much risk. Abbott has an above-average yield of 2.2% and has increased its dividend annually for 50 years. The home improvement retailer is in good shape to grow in the future.
The Motley Fool · 1d ago
Spinoffs Can Pay Juicy Dividends. 6 New Ones to Play.
Barron‘s · 1d ago
Abbott Laboratories Breaks Above 200-Day Moving Average - Bullish for ABT
NASDAQ · 2d ago
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
NASDAQ · 2d ago
Watchman In Focus As Boston Scientific Reports Its Q2
NASDAQ · 2d ago
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
NASDAQ · 3d ago
LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Seeking Alpha · 3d ago
Up 25% This Year, Will The Solid Q2 Performance Help Intuitive Surgical Stock Extend Its Winning Streak?
NASDAQ · 3d ago
See Which Of The Latest 13F Filers Holds Abbott Laboratories
NASDAQ · 4d ago
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.